UBE2T and prostate carcinoma: Wen et al. found that UBE2T exhibits oncogenic properties in human prostate cancer and suggested that UBE2T overexpression was sufficient to induce epithelial-mesenchymal transition of PCa cells as well as promote tumor growth and metastasis by cooperating with vimentin [24].